In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FEI Women's Health LLC

Division of Teva Pharmaceutical Industries Ltd.

Latest From FEI Women's Health LLC

Bayer IUD Could Get Boost From Revised ACOG Guidance On Adolescent Contraception

Skyla (levonorgestrel-releasing intrauterine system) is the first new IUD to the U.S. market in over a decade; Bayer plans to focus its marketing on women who have not had a child.

BioPharmaceutical United States

Drug Delivery Start-ups

Knowing that the competition's tougher, the new crop of drug delivery companies grows increasingly specialized.

FEI Drug Delivery Systems

FEI is developing a line a non-bioerodible polymer drug delivery implants for long-term drug delivery.
BioPharmaceutical Medical Device
See All

Company Information